SEC Filing Summary: Tempur-Pedic International Inc. (10-Q)
Business Context and Reporting Period
This is a Quarterly Report on Form 10-Q for Tempur-Pedic International Inc. for the period ended September 30, 2004. The company is a vertically-integrated manufacturer and marketer of premium visco-elastic mattresses and pillows, operating in two segments: Domestic (U.S.) and International (primarily Denmark). The company sells products in 60 countries under the Tempur and Tempur-Pedic brands.
Key Financial Metrics
| Metric (in thousands) | Three Months Ended Sept 30, 2004 |
Nine Months Ended Sept 30, 2004 |
|---|---|---|
| Net Sales | $181,737 | $486,460 |
| Gross Profit | $96,080 | $258,232 |
| Gross Margin | 53% | 53% |
| Operating Income | $42,835 | $106,358 |
| Operating Margin | 24% | 22% |
| Net Income | $22,411 | $51,127 |
| Diluted EPS | $0.22 | $0.50 |
| Cash from Operations (9mo) | $55,729 | |
| Total Debt (Book Value) | $295,896 | |
| Cash and Equivalents | $25,174 |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 47% year-over-year for the quarter and 42% for the nine-month period. Growth was driven primarily by the Domestic Retail channel, which grew 77% in the quarter and 72% for the nine months.
- Profitability: Operating income surged 89% in the quarter and 47% for the nine months. Net income increased significantly, rising from $325,000 in the prior year quarter to $22.4 million, and from $26.0 million to $51.1 million for the nine-month period.
- Debt Reduction: The company redeemed $52.5 million of Senior Subordinated Notes in January 2004 using IPO proceeds, resulting in a $5.4 million loss on extinguishment of debt recorded in the nine-month period.
- Expense Trends: Selling expenses increased 32% in the quarter but decreased as a percentage of sales (19% vs. 21% prior year) due to sales volume growth. General and administrative expenses increased 29%, partly due to Sarbanes-Oxley implementation costs and stock-based compensation.
Guidance, Outlook, and Risks
- Capital Expenditures: The company expects 2004 capital expenditures to be approximately $47.3 million, including $16.0 million for European facility expansion and $13.0 million for a new manufacturing facility in Albuquerque, New Mexico.
- Outlook: Management anticipates continued growth in the retail channel but notes that operating results are subject to seasonal fluctuations (typically higher in Q1 and Q3).
- Key Risks:
- Competition: Intense competition from established mattress manufacturers and lower-priced alternatives.
- Regulatory: Potential new fire retardancy standards (e.g., California 2005) could increase costs.
- Supply Chain: Reliance on two primary suppliers for polyol (a key raw material) and potential disruptions in manufacturing facilities.
- Financial Leverage: High debt levels ($295.9 million) limit flexibility and increase vulnerability to economic downturns.
- Intellectual Property: The principal product formula is not patented, relying on trade secrets which may be vulnerable to reverse engineering.
Investor Verification Checklist
- Debt Covenants: Verify compliance with the amended Senior Credit Facility covenants, specifically the minimum interest coverage and maximum leverage ratios.
- Return Rates: Monitor the 6-7% return rate in the U.S. to ensure it remains within historical estimates, as increases could materially impact liquidity.
- Warranty Reserves: Review the adequacy of the $3.6 million warranty reserve given the long-term nature of mattress warranties (15-20 years) and limited historical data for newer products.
- Customer Concentration: Assess the impact of the top five customers, who accounted for 13% of net sales in the nine-month period.
- Capital Project Costs: Track actual vs. estimated costs for the New Mexico facility expansion to ensure capital expenditure budgets are not exceeded.